Skip to content

Latest filings

Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.

DateCompanyInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 14, 2026ONMD
OneMedNet Corp
Golden Robert Lawrence
Chief Financial Officer
SOpen-market sale
Common Stock
-2,500$6.60$17k97,29123 h ago
Sep 15, 2026ONMD
OneMedNet Corp
Golden Robert Lawrence
Chief Financial Officer
SOpen-market sale
Common Stock
-3,000$6.30$19k94,29123 h ago
Sep 21, 2026ONMD
OneMedNet Corp
Golden Robert Lawrence
Chief Financial Officer
SOpen-market sale
Common Stock
-3,000$6.63$20k91,29123 h ago
Sep 22, 2026ONMD
OneMedNet Corp
Green Aaron
Chief Executive Officer
SOpen-market sale
Common Stock
-5,000$7.39$37k249,63823 h ago
Sep 24, 2026ONMD
OneMedNet Corp
Green Aaron
Chief Executive Officer
SOpen-market sale
Common Stock
-1,667$6.48$11k247,97123 h ago
Oct 8, 2026ULS
UL Solutions Inc.
Scanlon Jennifer F.
President and CEO
SOpen-market sale
Class A Common Stock10b5-1
-12,500$70.08$876k126,72424 h ago
Oct 7, 2026IHT
INNSUITES HOSPITALITY TRUST
WIRTH JAMES F
President & CEO
SOpen-market sale
INNSUITES HOSPITALITY REIT10b5-1
-43,111$50,410.80$2.2B7,940,27524 h ago
Oct 8, 2026MAX
MediaAlpha, Inc.
Yi Steven
See Remarks
SOpen-market sale
Class A Common Stock10b5-1
-24,000$10.04$241k2,315,74024 h ago
Oct 9, 2026MAX
MediaAlpha, Inc.
Yi Steven
See Remarks
SOpen-market sale
Class A Common Stock10b5-1
-2,033$11.01$22k2,313,70724 h ago
Oct 8, 2026MRVL
Marvell Technology, Inc.
Scarpulla Justin
SVP, Chief Accounting Officer
SOpen-market sale
Common Stock
-1,100$273.59$301k90924 h ago
Oct 7, 2026BETA
BETA Technologies, Inc.
Clark Kyle
SEE REMARKS
SOpen-market sale
Class A common stockindirect: By The Godric's Hollow Trust10b5-1
-10,000$20.19$202k5,135,93625 h ago
Oct 8, 2026BETA
BETA Technologies, Inc.
Clark Kyle
SEE REMARKS
SOpen-market sale
Class A common stockindirect: By The Godric's Hollow Trust10b5-1
-10,000$20.37$204k5,125,93625 h ago
Oct 9, 2026BETA
BETA Technologies, Inc.
Clark Kyle
SEE REMARKS
SOpen-market sale
Class A common stockindirect: By The Godric's Hollow Trust10b5-1
-10,000$20.66$207k5,115,93625 h ago
Oct 9, 2026PANW
Palo Alto Networks Inc
Bawa Aparna
director
SOpen-market sale
Common Stockindirect: See footnote
-170$410.00$70k4,50725 h ago
Oct 9, 2026PANW
Palo Alto Networks Inc
Bawa Aparna
director
SOpen-market sale
Common Stockindirect: See footnote
-80$417.13$33k4,42725 h ago
Oct 7, 2026ANET
Arista Networks, Inc.
Ullal Jayshree
CEO and Chairperson
SOpen-market sale
Common Stockindirect: By Trust for Child 110b5-1
-13,860$217.14$3.0M4,797,34725 h ago
Oct 7, 2026ANET
Arista Networks, Inc.
Ullal Jayshree
CEO and Chairperson
SOpen-market sale
Common Stockindirect: By Trust for Child 210b5-1
-13,860$217.14$3.0M4,797,34725 h ago
Oct 7, 2026ANET
Arista Networks, Inc.
Ullal Jayshree
CEO and Chairperson
SOpen-market sale
Common Stockindirect: by Trust10b5-1
-69,272$217.14$15M15,545,73825 h ago
Oct 8, 2026PCRX
Pacira BioSciences, Inc.
RIKER LAUREN
Senior Vice President, Finance
SOpen-market sale
Common Stock10b5-1
-6,000$36.32$218k62,28425 h ago
Oct 8, 2026SAIL
SailPoint, Inc.
REZVAN MITRA
Chief Accounting Officer
SOpen-market sale
Common Stock10b5-1
-1,168$20.00$23k173,17225 h ago
Oct 7, 2026ALAB
Astera Labs, Inc.
Dyckerhoff Stefan A
director
SOpen-market sale
Common Stock10b5-1
-3,505$376.06$1.3M47,01926 h ago
Oct 7, 2026ALAB
Astera Labs, Inc.
Dyckerhoff Stefan A
director
SOpen-market sale
Common Stockindirect: By Trust10b5-1
-8,333$376.06$3.1M286,40026 h ago
Oct 7, 2026ALAB
Astera Labs, Inc.
Dyckerhoff Stefan A
director
SOpen-market sale
Common Stockindirect: By Limited Partnership (TF)10b5-1
-661$376.06$249k2,64826 h ago
Oct 9, 2026ZYME
Zymeworks Inc.
Schayowitz Adam
EVP, Head of R&D
SOpen-market sale
Common Stock
-13,832$25.85$358k23,20526 h ago
Jun 15, 2026EVRG
Evergy, Inc.
Caisley Charles A.
EVP & CHIEF CUST OFFCR
SOpen-market sale
Common Stock
-1,198$83.46$100k36,59128 h ago
Dec 27, 2024ARIS
Aris Water Solutions, Inc.
Gable S Corp
other
SOpen-market sale
Class A Common Stockindirect: See Footnotes
-3,641$25.02$91k2,631,150Dec 31, 2024
Dec 30, 2024RAMP
LiveRamp Holdings, Inc.
Bloomston Kimberly
CHIEF PRODUCT OFFICER
SOpen-market sale
COMMON STOCK, $.10 PAR VALUE10b5-1
-9,729$30.41$296k99,130Dec 31, 2024
Dec 30, 2024CNXC
Concentrix Corp
Twomey Cormac J
EVP, Global Ops & Delivery
SOpen-market sale
Common Stock10b5-1
-500$44.05$22k23,936Dec 31, 2024
Dec 31, 2024ARQT
Arcutis Biotherapeutics, Inc.
Burnett Patrick
See Remarks
SOpen-market sale
Common Stock10b5-1
-1,691$14.00$24k126,978Dec 31, 2024
Dec 30, 2024ACVA
ACV Auctions Inc.
ZERELLA WILLIAM
Chief Financial Officer
SOpen-market sale
Class A Common Stock10b5-1
-32,500$21.65$704k490,482Dec 31, 2024
Dec 30, 2024SOAR
Volato Group, Inc.
Cooper Nicholas James
Chief Commercial Officer
SOpen-market sale
Common Stock
-459,005$0.26$120k3,353,560Dec 31, 2024
Dec 30, 2024CRDO
Credo Technology Group Holding Ltd
Lam Yat Tung
Chief Operating Officer
SOpen-market sale
Ordinary Sharesindirect: By Chung BVI Co Ltd10b5-1
-18,827$67.84$1.3M381,173Dec 31, 2024
Dec 30, 2024CRDO
Credo Technology Group Holding Ltd
Lam Yat Tung
Chief Operating Officer
SOpen-market sale
Ordinary Sharesindirect: By Chung BVI Co Ltd10b5-1
-13,900$68.83$957k367,273Dec 31, 2024
Dec 30, 2024CRDO
Credo Technology Group Holding Ltd
Lam Yat Tung
Chief Operating Officer
SOpen-market sale
Ordinary Sharesindirect: By Chung BVI Co Ltd10b5-1
-47,209$69.92$3.3M320,064Dec 31, 2024
Dec 30, 2024CRDO
Credo Technology Group Holding Ltd
Lam Yat Tung
Chief Operating Officer
SOpen-market sale
Ordinary Sharesindirect: By Chung BVI Co Ltd10b5-1
-20,064$70.65$1.4M300,000Dec 31, 2024
Dec 30, 2024UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
SOpen-market sale
Common Stockindirect: By Trust10b5-1
-1,318$355.46$468k6,182Dec 31, 2024
Dec 30, 2024UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
SOpen-market sale
Common Stockindirect: By Trust10b5-1
-3,025$356.38$1.1M3,157Dec 31, 2024
Dec 30, 2024UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
SOpen-market sale
Common Stockindirect: By Trust10b5-1
-2,757$357.28$985k400Dec 31, 2024
Dec 30, 2024UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
SOpen-market sale
Common Stockindirect: By Trust10b5-1
-400$358.18$143k0Dec 31, 2024
Dec 30, 2024UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
SOpen-market sale
Common Stockindirect: By Trust10b5-1
-500$355.69$178k2,000Dec 31, 2024
Dec 30, 2024UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
SOpen-market sale
Common Stockindirect: By Trust10b5-1
-820$356.51$292k1,180Dec 31, 2024
Dec 30, 2024UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
SOpen-market sale
Common Stockindirect: By Trust10b5-1
-1,080$357.37$386k100Dec 31, 2024
Dec 30, 2024UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
SOpen-market sale
Common Stockindirect: By Trust10b5-1
-100$358.17$36k0Dec 31, 2024
Dec 30, 2024SPT
Sprout Social, Inc.
Barretto Ryan Paul
CEO
SOpen-market sale
Class A Common Stockindirect: See Footnote10b5-1
-16,800$30.99$521k153,375Dec 31, 2024
Dec 31, 2024CCLD
CareCloud, Inc.
DALY JOHN N
director
SOpen-market sale
Common Stock
-5,000$3.87$19k61,750Dec 31, 2024
Dec 27, 2024SKYH
Sky Harbour Group Corp
BOSTON OMAHA Corp
owner
SOpen-market sale
Class A common stock, par value $0.001 per share
-15,904$12.21$194k10,912,907Dec 31, 2024
Dec 30, 2024SKYH
Sky Harbour Group Corp
BOSTON OMAHA Corp
owner
SOpen-market sale
Class A common stock, par value $0.001 per share
-9,077$12.06$109k10,903,830Dec 31, 2024
Dec 31, 2024SKYH
Sky Harbour Group Corp
BOSTON OMAHA Corp
owner
SOpen-market sale
Class A common stock, par value $0.001 per share
-14,072$12.06$170k10,889,758Dec 31, 2024
Dec 27, 2024VOR
Vor Biopharma Inc.
Attar Eyal C.
CHIEF MEDICAL OFFICER
SOpen-market sale
Common Stock10b5-1
-10,334$1.25$13k81,439Dec 31, 2024
Dec 27, 2024ORGN
Origin Materials, Inc.
Bissell John
CEO and Director
SOpen-market sale
Common Stock
-55,000$1.00$55k1,976,230Dec 31, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.